No plasmodium falciparum chloroquine resistance transporter and artemisinin resistance mutations, Haiti

7Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

We obtained 78 human blood samples from areas in Haiti with high transmission of malaria and found no drug resistance-associated mutations in Plasmodium falciparum chloroquine resistance transporter and Kelch 13 genes. We recommend maintaining chloroquine as the first-line drug for malaria in Haiti. Artemisinin-based therapy can be used as alternative therapy.

Cite

CITATION STYLE

APA

Vincent, J. P., Komaki-Yasuda, K., Existe, A. V., Boncy, J., & Kano, S. (2018, November 1). No plasmodium falciparum chloroquine resistance transporter and artemisinin resistance mutations, Haiti. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2411.180738

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free